Biocon Crosses $1bn Threshold In Biosimilars Revenue

Wider Results Met With Analyst Uncertainty

 
• By Adam Zamecnik
Indian Economy Growth, Indian Rupee Growth
• Source: Shutterstock

More from Biosimilars

More from Products